Facebook
Twitter
LinkedIn

FAST Company

Argonaut Genomics

Argonaut Genomics is an early stage biopharma focused on developing novel cancer antigens in solid tumors for therapeutic cancer vaccines and cell therapies. We envision a line of precision biologics based on tumor antigens widely shared across patients that can be manufactured as off-the-shelf products for treating and preventing cancer.